Nitrome Biosciences Raises $38M Series A Financing to Advance Therapeutics Targeting a Novel Group of Enzymes involved in Age-related Diseases

from Venture Capital Access Online: Latest Venture Capital and Private Equity News https://ift.tt/3byUpui
via IFTTT